Toxicity and Data Limitations: No chronic toxicity data exist for this blend
That's partly because the FDA crackdown on peptides has intensified in recent years, just as pharmaceutical compounding (a sort of acceptable way to get knock off medications) has surged in popularity, with people seeking cheaper versions of GLP-1 drugs like Ozempic and Mounjaro
Peptide-based strategies for targeted breast cancer Breast cancer, as an invasive cancer, starts in the breast tissue and spreads to the milk-producing lobules and ducts
Tested Applications Recommended dilution Published Applications Product Information 66323-2-Ig targets Glutamine Synthetase in WB, IHC, IF-P, IF-Fro, FC (Intra), ELISA applications and shows reactivity with human, mouse, rat samples.